Jinlei Zhang

Title: The Innovative Contributions of Jinlei Zhang

Introduction

Jinlei Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin formulations. His innovative approach has led to advancements that benefit both the medical community and patients requiring insulin therapy.

Latest Patents

Jinlei Zhang holds a patent for a method of preparing insulin glargine crystals. The patent, titled "Method for preparing insulin glargine crystal," discloses a process that involves crystallizing insulin glargine at a pH of 7.0-9.0. The crystallization solution contains a recombinant insulin glargine, an organic solvent at a 10-30% concentration by volume, a zinc compound, a phenol derivative, a salt, and an organic acid. This innovative method enhances the stability and efficacy of insulin glargine, which is crucial for diabetes management.

Career Highlights

Jinlei Zhang is currently employed at Gan & Lee Pharmaceuticals, a company known for its focus on diabetes care and insulin products. His work at the company has positioned him as a key player in the development of advanced insulin therapies. With a patent portfolio that includes one significant patent, Zhang continues to contribute to the pharmaceutical industry.

Collaborations

Throughout his career, Jinlei Zhang has collaborated with notable colleagues, including Damei Wang and Wenjie Li. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical solutions.

Conclusion

Jinlei Zhang's contributions to the field of insulin formulation exemplify the impact of innovative thinking in pharmaceuticals. His patent for the method of preparing insulin glargine crystals showcases his commitment to improving diabetes treatment. As he continues to work at Gan & Lee Pharmaceuticals, his future endeavors are likely to yield further advancements in the industry.